Page last updated: 2024-08-16

thiram and raclopride

thiram has been researched along with raclopride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Csiba, L; Donohou, SR; Farkas, S; Gulyás, B; Halldin, C; Harkany, T; Jia, Z; Máthé, D; Nagy, K; Palkovits, M; Pike, VW	1

Other Studies

1 other study(ies) available for thiram and raclopride

Article	Year
The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagoni Brain research bulletin, 2012, Apr-10, Volume: 87, Issue:6 Topics: Aged; Autoradiography; Case-Control Studies; Caudate Nucleus; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Parkinson Disease; Protein Binding; Putamen; Pyrazoles; Raclopride; Radionuclide Imaging; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiram	2012

Article

Year

The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagoni

Brain research bulletin, 2012, Apr-10, Volume: 87, Issue:6

Topics: Aged; Autoradiography; Case-Control Studies; Caudate Nucleus; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Parkinson Disease; Protein Binding; Putamen; Pyrazoles; Raclopride; Radionuclide Imaging; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiram

2012